Answers are grounded in this paper and cite their sources.
Researchers demonstrate enhanced bone repair in osteonecrosis using exosome-rich scaffolds, suggesting a new treatment method.
Osteonecrosis of the femoral head (ONFH) is a debilitating bone disorder characterized by ischemic degeneration with limited therapeutic options. Piezo1, a mechanosensitive ion channel, transduces physical stimuli into intracellular signals regulating osteogenesis and angiogenesis. Here, we developed a 3D-printed Ti6Al4V scaffold conformally coated with photocrosslinked hyaluronic acid hydrogel that retains and releases Piezo1-engineered exosomes (P-Exos), forming a hybrid construct (P-Exos@HAMA/Ti) with cancellous-bone-like stiffness and sustained bioactivity. In vitro studies demonstrated that P-Exos enhanced BMSC viability, migration, and osteogenic differentiation (ALP/ARS; Runx2, Osterix, OCN) while promoting endothelial proliferation and network formation (CD31, VEGFA). RNA-seq and mechanistic validation revealed Ca2+-responsive YAP1/β-catenin signaling, characterized by elevated intracellular Ca2+ levels, upregulated YAP1/β-catenin expression, and nuclear localization, underpinning the scaffold’s osteo-angiogenic synergy. In a rat ONFH model, P-Exos@HAMA/Ti restored trabecular architecture and bone volume, improved micro-CT indices (increased BV/TV, Tb.N, Tb.Th; decreased Tb.Sp), and enhanced osteogenic/angiogenic marker expression, alongside superior locomotor recovery. This multifunctional platform couples mechanical stabilization with Piezo1-mediated mechanotransduction, establishing a pro-regenerative niche integrating biomechanical support with sustained exosomal signaling for effective repair of ischemic bone defects.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: